NCT07090564View on ClinicalTrials.gov

Treatment Outcomes in PASC Patients With Neurocognitive Impairment

CompletedOBSERVATIONAL
Enrollment

171

Participants

Timeline

Start Date

October 12, 2022

Primary Completion Date

March 31, 2024

Study Completion Date

April 1, 2024

Conditions
Long COVID
Trial Locations (1)

43203

The Ohio State University Wexner Medical Center, Columbus

All Listed Sponsors
lead

Ohio State University

OTHER